中国防痨杂志 ›› 2026, Vol. 48 ›› Issue (5): 716-622.doi: 10.19982/j.issn.1000-6621.20250474
赖晓宇, 廖庆华, 温文沛(
), 郭卉欣, 林伟斌, 陈珣珣(
)
收稿日期:2025-12-02
出版日期:2026-05-10
发布日期:2026-04-27
通信作者:
温文沛,陈珣珣
E-mail:grace_chen514@163.com;wwp_yb@126.com
基金资助:
Lai Xiaoyu, Liao Qinghua, Wen Wenpei(
), Guo Huixin, Lin Weibin, Chen Xunxun(
)
Received:2025-12-02
Online:2026-05-10
Published:2026-04-27
Contact:
Wen Wenpei,Chen Xunxun
E-mail:grace_chen514@163.com;wwp_yb@126.com
Supported by:摘要:
结核性葡萄膜炎(tuberculous uveitis, TBU)是眼内结核最常见的表现形式,其发病率在全球范围内呈上升趋势,是临床导致视力损伤乃至失明的重要感染性眼病原因之一。TBU的诊断和治疗极具挑战性,其核心难点在于复杂的发病机制尚未完全阐明。长期以来,关于TBU是由结核分枝杆菌(Mycobacterium tuberculosis, MTB)直接感染眼内组织,还是由远处感染灶引起的免疫超敏反应,抑或是涉及自身免疫的分子模拟机制,一直存在争论。近年来,随着免疫学和分子生物学技术的飞速发展,业界对TBU发病过程的理解取得了长足的进步。目前普遍认为,TBU的发病并非单一机制所能解释,而是一个涉及病原体、宿主免疫应答及眼部微环境三者动态相互作用的复杂病理过程。本文旨在系统梳理TBU的发现历程与概念演进,深入探讨其各种发病机制假说及其研究证据,总结当前公认的整合性发病机制,并重点阐述在宿主遗传易感性、关键免疫细胞亚群(如Th1/Th17细胞)、细胞因子网络及MTB毒力因子等领域的最新研究进展,以期为未来的基础研究和临床诊疗提供新的思路和方向。
中图分类号:
赖晓宇, 廖庆华, 温文沛, 郭卉欣, 林伟斌, 陈珣珣. 结核性葡萄膜炎的发病机制研究进展[J]. 中国防痨杂志, 2026, 48(5): 716-622. doi: 10.19982/j.issn.1000-6621.20250474
Lai Xiaoyu, Liao Qinghua, Wen Wenpei, Guo Huixin, Lin Weibin, Chen Xunxun. Advances in the research on the pathogenesis of tuberculous uveitis[J]. Chinese Journal of Antituberculosis, 2026, 48(5): 716-622. doi: 10.19982/j.issn.1000-6621.20250474
| [1] | Alli HD, Ally N, Mayet I, et al. Global prevalence and clinical outcomes of tubercular uveitis: a systematic review and meta-analysis. Surv Ophthalmol, 2022, 67(3):770-792. doi:10.1016/j.survophthal.2021.10.001. |
| [2] |
Standardization of Uveitis Nomenclature (SUN) Working Group. Classification Criteria for Tubercular Uveitis. Am J Ophthalmol, 2021, 228:142-151. doi:10.1016/j.ajo.2021.03.040.
URL pmid: 33845014 |
| [3] |
Aggarwal K, Agarwal A, Deokar A, et al. Ultra-Wide Field Imaging in Paradoxical Worsening of Tubercular Multifocal Serpiginoid Choroiditis after the Initiation of Anti-Tubercular Therapy. Ocul Immunol Inflamm, 2019, 27(3):365-370. doi:10.1080/09273948.2017.1373829.
URL pmid: 29020501 |
| [4] | Betzler BK, Gunasekeran DV, Kempen J, et al. The Historical Evolution of Ocular Tuberculosis: Past, Present, and Future. Ocul Immunol Inflamm, 2022, 30(3):593-599. doi:10.1080/09273948.2021.1992446. |
| [5] |
Agrawal R, Gunasekeran DV, Grant R, et al. Clinical Features and Outcomes of Patients With Tubercular Uveitis Treated With Antitubercular Therapy in the Collaborative Ocular Tuberculosis Study (COTS)-1. JAMA Ophthalmol, 2017, 135(12):1318-1327. doi:10.1001/jamaophthalmol.2017.4485.
URL pmid: 29075752 |
| [6] | Albert DM, Raven ML. Ocular tuberculosis. Microbiol Spectr, 2016, 4 (6):TNMI7-0001-2016. doi:10.1128/microbiolspec.TNMI7-0001-2016. |
| [7] | Koch R. Professor Koch’s remedy for tuberculosis: A further communication on a remedy for tuberculosis. Indian J Med Res, 2023, 157(2/3):169-173. doi:10.4103/0971-5916.373948. |
| [8] |
Woods AC, Wood RM, Naquin HA. Studies in experimental ocular tuberculosis. Effect of streptomycin and promizole in experimental ocular tuberculosis in the normal rabbit. Arch Ophthal, 1950, 43(5):834-844.
pmid: 15414081 |
| [9] | Coelho Filho JC, Takenami I, Arruda S. Revisiting the Rich’s formula: an update about granulomas in human tuberculosis. Braz J Infect Dis, 2013, 17(2):234-238. doi:10.1016/j.bjid.2013.01.006. |
| [10] | Abdisamadov A, Tursunov O. Ocular tuberculosis epidemiology, clinic features and diagnosis: A brief review. Tuberculosis (Edinb), 2020, 124:101963. doi:10.1016/j.tube.2020.101963. |
| [11] | Chawla R, Singh MK, Singh L, et al. Tubercular DNA PCR of ocular fluids and blood in cases of presumed ocular tuberculosis: a pilot study. Ther Adv Ophthalmol, 2022, 14:25158414221123522. doi:10.1177/25158414221123522. |
| [12] | Sharma K, Sharma M, Joshi H, et al. Evaluation of Mycobacterium Tuberculosis Derived Cell-Free DNA-Based Multi-Targeted Real-Time PCR from Vitreous Fluid (VF) Samples to Diagnose Ocular Tuberculosis. Ocul Immunol Inflamm, 2025, 33(9):1907-1912. doi:10.1080/09273948.2025.2532820. |
| [13] | Putera I, Schrijver B, Ten Berge JCEM, et al. The immune response in tubercular uveitis and its implications for treatment: From anti-tubercular treatment to host-directed therapies. Prog Retin Eye Res, 2023, 95:101189. doi:10.1016/j.preteyeres.2023.101189. |
| [14] | Damera SK, Panigrahi RK, Mitra S, et al. Role of Extracellular Mycobacteria in Blood-Retinal Barrier Invasion in a Zebrafish Model of Ocular TB. Pathogens, 2021, 10(3):333. doi:10.3390/pathogens10030333. |
| [15] | Dalvin LA, Smith WM. Intraocular manifestations of mycobacterium tuberculosis: A review of the literature. J Clin Tuberc Other Mycobact Dis, 2017, 7:13-21. doi:10.1016/j.jctube.2017.01.003. |
| [16] |
Aggarwal K, Agarwal A, Sehgal S, et al. An unusual presentation of intraocular tuberculosis in a monocular patient: clinicopathological correlation. J Ophthalmic Inflamm Infect, 2016, 6 (1): 46. doi:10.1186/s12348-016-0118-8.
URL pmid: 27888495 |
| [17] | Basu S, Elkington P, Rao NA. Pathogenesis of ocular tuberculosis: New observations and future directions. Tuberculosis (Edinb), 2020, 124:101961. doi:10.1016/j.tube.2020.101961. |
| [18] |
Yeh S, Sen HN, Colyer M, et al. Update on ocular tuberculosis. Curr Opin Ophthalmol, 2012, 23(6):551-556. doi:10.1097/ICU.0b013e328358ba01.
URL pmid: 23047173 |
| [19] |
Kataria P, Kumar A, Bansal R, et al. devR PCR for the diagnosis of intraocular tuberculosis. Ocul Immunol Inflamm, 2015, 23(1):47-52. doi:10.3109/09273948.2014.981550.
URL pmid: 25615810 |
| [20] | Sharma K, Gupta A, Sharma M, et al. Detection of viable Mycobacterium tuberculosis in ocular fluids using mRNA-based multiplex polymerase chain reaction. Indian J Med Microbiol, 2022, 40(2):254-257. doi:10.1016/j.ijmmb.2021.12.019. |
| [21] |
Konana VK, Babu K. Current concepts in the diagnosis of ocular tuberculosis: A narrative review. Taiwan J Ophthalmol, 2025, 15 (2): 203-211. doi:10.4103/tjo.TJO-D-24-00115.
URL pmid: 40584192 |
| [22] |
Balne PK, Modi RR, Choudhury N, et al. Factors influencing polymerase chain reaction outcomes in patients with clinically suspected ocular tuberculosis. J Ophthalmic Inflamm Infect, 2014, 4(1):10. doi:10.1186/1869-5760-4-10.
URL pmid: 24661354 |
| [23] | Kaur K, Laal S, Ryndak MB. Mycobacterium tuberculosis transcriptome in intraocular tuberculosis. J Med Microbiol, 2023, 72(2). doi:10.1099/jmm.0.001649. |
| [24] |
Ganesh SK, Abraham S, Sudharshan S. Paradoxical reactions in ocular tuberculosis. J Ophthalmic Inflamm Infect, 2019, 9(1):19. doi:10.1186/s12348-019-0183-x.
URL pmid: 31493128 |
| [25] |
Ohara H, Harada Y, Hiyama T, et al. Incidence of ocular inflammation among patients with active tuberculosis or nontuberculous mycobacterial infections in a tertiary hospital in Japan. Int Ophthalmol, 2021, 41(4):1427-1436. doi:10.1007/s10792-021-01718-z.
URL pmid: 33475908 |
| [26] | Multani PK, Modi R, Basu S. Pattern of Recurrent Inflammation following Anti-tubercular Therapy for Ocular Tuberculosis. Ocul Immunol Inflamm, 2022, 30(1):185-190. doi:10.1080/09273948.2020.1772838. |
| [27] | Fernández-Zamora Y, Finamor LP, Silva LMP, et al. Role of Interferon-Gamma Release Assay for the Diagnosis and Clinical Follow up in Ocular Tuberculosis. Ocul Immunol Inflamm, 2023, 31(2):304-311. doi:10.1080/09273948.2022.2027459. |
| [28] | Alam K, Sharma G, Forrester JV, et al. Antigen-Specific Intraocular Cytokine Responses Distinguish Ocular Tuberculosis From Undifferentiated Uveitis in Tuberculosis-Immunoreactive Patients. Am J Ophthalmol, 2023, 246:31-41. doi:10.1016/j.ajo.2022.08.029. |
| [29] | Shree R, Mahesh KV, Takkar A, et al. The Neuro-Ophthalmology of Tuberculosis. Neuroophthalmology, 2023, 48(2):73-92. doi:10.1080/01658107.2023.2281435. |
| [30] | Gusmão CC, Dos Reis R, Litvoc MN, et al. Paradoxical Reaction in Intraocular Tuberculosis: Report of Three Cases. Ocul Immunol Inflamm, 2024, 32(10):2562-2567. doi:10.1080/09273948.2024.2372314. |
| [31] | Kon OM, Beare N, Connell D, et al. BTS clinical statement for the diagnosis and management of ocular tuberculosis. BMJ Open Respir Res, 2022, 9(1):e001225. doi:10.1136/bmjresp-2022-001225. |
| [32] | Biswas J, Therese L, Madhavan HN. Use of polymerase chain reaction in detection of Mycobacterium tuberculosis complex DNA from vitreous sample of Eales’ disease. Br J Ophthalmol, 1999, 83(8):994. doi:10.1136/bjo.83.8.994. |
| [33] | Agrawal R, Testi I, Rousselot A, et al. Insights into the molecular pathogenesis of ocular tuberculosis. Tuberculosis (Edinb), 2021, 126:102018. doi:10.1016/j.tube.2020.102018. |
| [34] | Nandi K, Panda AK, Chakraborty A, et al. Role of ATP-Small Heat Shock Protein Interaction in Human Diseases. Front Mol Biosci, 2022, 9:844826. doi:10.3389/fmolb.2022.844826. |
| [35] | Kutlutürk Karagöz I, Kaya M, Kıvrak U, et al. Exploring the Molecular Intersection of Posterior Ocular Tuberculosis: Mycobacterium tuberculosis Proteins, Ocular Autoimmunity, and Immune Receptor Interactions. Ophthalmol Sci, 2024, 5(3):100698. doi:10.1016/j.xops.2024.100698. |
| [36] |
Wroblewski KJ, Hidayat AA, Neafie RC, et al. Ocular tuberculosis: a clinicopathologic and molecular study. Ophthalmology, 2011, 118(4):772-777. doi:10.1016/j.ophtha.2010.08.011.
URL pmid: 21055814 |
| [37] | Adamus G. Are Anti-Retinal Autoantibodies a Cause or a Consequence of Retinal Degeneration in Autoimmune Retinopa-thies?. Front Immunol, 2018, 9:765. doi:10.3389/fimmu.2018.00765. |
| [38] | Wildner G, Diedrichs-Möhring M. Molecular Mimicry and Uveitis. Front Immunol, 2020, 11:580636. doi:10.3389/fimmu.2020.580636. |
| [39] | Zhang YK, Guan Y, Zhao J, et al. Diagnosis of tuberculous uveitis by the macrogenome of intraocular fluid: A case report and review of the literature. World J Clin Cases, 2023, 11(14):3248-3255. doi:10.12998/wjcc.v11.i14.3248. |
| [40] |
Papasavvas I, Jeannin B, Herbort CP. Tuberculosis-related serpiginous choroiditis: aggressive therapy with dual concomitant combination of multiple anti-tubercular and multiple immunosuppressive agents is needed to halt the progression of the disease. J Ophthalmic Inflamm Infect, 2022, 12(1):7. doi:10.1186/s12348-022-00282-6.
URL pmid: 35132499 |
| [41] | Brar M, Sharma M, Grewal S, et al. Longitudinal study of serpiginous choroiditis and serpiginous like choroiditis using wide field OCT angiography. Eur J Ophthalmol, 2022, 32(3):1555-1561. doi:10.1177/11206721211028529. |
| [42] | Shah JS, Shetty N, Shah SK, et al. Tubercular Uveitis with Ocular Manifestation as the First Presentation of Tuberculosis: A Case Series. J Clin Diagn Res, 2016, 10(3):NR01-3. doi:10.7860/JCDR/2016/16219.7375. |
| [43] | 赖晓宇, 段鸿飞, 陈珣珣, 等. 结核性葡萄膜炎临床特征,诊断策略与分级标准研究进展. 中国防痨杂志, 2025, 47(9):1204-1211. doi:10.19982/j.issn.1000-6621.20250196. |
| [44] | Welin A, Björnsdottir H, Winther M, et al. CFP-10 from Mycobacterium tuberculosis selectively activates human neutrophils through a pertussis toxin-sensitive chemotactic receptor. Infect Immun, 2015, 83(1):205-213. doi:10.1128/IAI.02493-14. |
| [45] |
Renshaw PS, Lightbody KL, Veverka V, et al. Structure and function of the complex formed by the tuberculosis virulence factors CFP-10 and ESAT-6. EMBO J, 2005, 24(14):2491-2498. doi:10.1038/sj.emboj.7600732.
URL pmid: 15973432 |
| [46] | van Leeuwen LM, Boot M, Kuijl C, et al. Mycobacteria employ two different mechanisms to cross the blood-brain barrier. Cell Microbiol, 2018, 20(9):e12858. doi:10.1111/cmi.12858. |
| [47] | Liu R, Dang JN, Lee R, et al. Mycobacterium dormancy and antibiotic tolerance within the retinal pigment epithelium of ocular tuberculosis. Microbiol Spectr, 2024, 12(8):e0078824. doi:10.1128/spectrum.00788-24. |
| [48] | 程奕喆, 呼风, 王茹, 等. 结核性葡萄膜炎患者房水的细胞因子含量研究. 眼科, 2023, 32(2):135-141. doi:10.13281/j.cnki.issn.1004-4469.2023.02.009. |
| [49] |
Ang M, Cheung G, Vania M, et al. Aqueous cytokine and chemokine analysis in uveitis associated with tuberculosis. Mol Vis, 2012, 18:565-573.
pmid: 22509092 |
| [50] | Putera I, La Distia Nora R, Ten Berge JCEM, et al. Diagnostic Biomarkers for Uveitis: Serum BAFF and CXCL 9 in Differentiating Ocular Sarcoidosis, Tuberculosis and Other Entities with Implication for QuantiFERON-Positive Uveitis. Ocul Immunol Inflamm, 2025, 33(8):1548-1560. doi:10.1080/09273948.2025.2493357. |
| [51] | Valenzuela RA, Vega-Tapia F, Elizalde N, et al. IL-10 and IL-6/IL-10 as predictive biomarkers for treatment response in non-infectious uveitis. Front Immunol, 2025, 16:1584905. doi:10.3389/fimmu.2025.1584905. |
| [52] | Chadalawada S, Kathirvel K, Lalitha P, et al. Dysregulated expression of microRNAs in aqueous humor from intraocular tuberculosis patients. Mol Biol Rep, 2022, 49(1):97-107. doi:10.1007/s11033-021-06846-4. |
| [53] | Davuluri KS, Chauhan DS. microRNAs associated with the pathogenesis and their role in regulating various signaling pathways during Mycobacterium tuberculosis infection. Front Cell Infect Microbiol, 2022, 12:1009901. doi:10.3389/fcimb.2022.1009901. |
| [54] |
Li R, Zheng SG, Zhou H. Metabolomics of ocular immune diseases. Metabolomics, 2025, 21(3):74. doi:10.1007/s11306-025-02273-9.
URL pmid: 40457094 |
| [55] | 肖媛媛, 毛羽, 曹绪胜, 等. 结核性葡萄膜炎初始抗结核治疗矛盾反应的临床特征. 眼科, 2022, 31(4):277-281. doi:10.13281/j.cnki.issn.1004-4469.2022.04.006. |
| [56] | Quinn CM, Poplin V, Kasibante J, et al. Tuberculosis IRIS: Pathogenesis, Presentation, and Management across the Spectrum of Disease. Life (Basel), 2020, 10(11):262. doi:10.3390/life10110262. |
| [57] | Nieto-Aristizábal I, Mera JJ, Giraldo JD, et al. From ocular immune privilege to primary autoimmune diseases of the eye. Autoimmun Rev, 2022, 21(8):103122. doi:10.1016/j.autrev.2022.103122. |
| [58] | Woodward R, Konda SM, Grewal DS. Autoimmune Inflammatory Eye Disease: Demystifying Clinical Presentations for the Internist. Curr Allergy Asthma Rep, 2023, 23(8):471-479. doi:10.1007/s11882-023-01088-9. |
| [59] |
Sharma RK, Sharma J, Khan ZK, et al. Diminished TLR2-TLR9 mediated CD4+ T cell responses are associated with increased inflammation in intraocular tuberculosis. Sci Rep, 2018, 8(1): 13812. doi:10.1038/s41598-018-32234-3.
URL pmid: 30218032 |
| [60] |
Basu S, Hassman L, Kodati S, et al. Intraocular Immune Response in Human Uveitis: Time to Look Beyond Animal Models. Am J Ophthalmol, 2024, 266:17-25. doi:10.1016/j.ajo.2024.04.026.
URL pmid: 38703799 |
| [61] | Tagirasa R, Parmar S, Barik MR, et al. Autoreactive T Cells in Immunopathogenesis of TB-Associated Uveitis. Invest Ophthalmol Vis Sci, 2017, 58(13):5682-5691. doi:10.1167/iovs.17-22462. |
| [1] | 热依汗古丽·阿肯, 木拉提江·艾买提, 高绪胜, 丁彩红, 曾谊, 陈禹, 白燕, 范琳. 60岁及以上老年肺结核患者营养不良与治疗转归的影响因素分析[J]. 中国防痨杂志, 2026, 48(6): 751-759. |
| [2] | 江西省胸科医院/江西省卫生健康结核病重点实验室, 中国防痨协会, 广州国家实验室. 乳腺结核诊断与治疗专家共识[J]. 中国防痨杂志, 2026, 48(6): 737-750. |
| [3] | 徐勇, 周腾, 刘俊佳. 结核性气道狭窄介入治疗后再狭窄风险预测模型的构建及验证[J]. 中国防痨杂志, 2026, 48(6): 760-768. |
| [4] | 范佳画, 颜亮, 陈华, 卢春丽, 汪敏, 黄亚玲, 李艳. 结核病与糖尿病共病患者营养风险、炎症指标与血糖控制的相关性分析[J]. 中国防痨杂志, 2026, 48(6): 769-778. |
| [5] | 王昕妍, 潘红芳, 梅雪, 张翼, 刘杰. 肺结核合并骨关节结核患者外周血临床检测指标特征分析[J]. 中国防痨杂志, 2026, 48(6): 779-786. |
| [6] | 李静, 陈双双, 陈春华, 杨国祥, 杨承闹, 郑禄云, 谭承建, 李传友, 李洁, 周培富, 代小伟. 民族药阴地蕨抗结核活性筛选及化学成分分析[J]. 中国防痨杂志, 2026, 48(6): 787-794. |
| [7] | 夏露, 穆婷婷, 蔡秋杰, 马艳, 龚蒙萌, 叶丹, 张炜. 基于证素辨证的619例重症肺结核患者中医证型特点分析[J]. 中国防痨杂志, 2026, 48(6): 795-802. |
| [8] | 郭宸浩, 刘鑫宇, 詹斯蕊, 王丽丽, 马梦婷, 李秀梅, 祁琳萍, 李卫平. γ-干扰素释放试验诊断成人肺外结核准确性的系统综述与荟萃分析[J]. 中国防痨杂志, 2026, 48(6): 803-812. |
| [9] | 张玥, 黄金鹏, 高丹, 凌琳. 数字技术管理下老年结核病患者服药依从性现状及影响因素探讨[J]. 中国防痨杂志, 2026, 48(6): 813-820. |
| [10] | 张雅莹, 王森路, 古丽孜巴·库尔班江, 阿卜力克木·艾力, 梁辰, 袁双龙, 李彩虹, 曹明芹. 新疆维吾尔自治区南疆地区肺结核患者治疗相关心理负担影响因素及其作用路径分析[J]. 中国防痨杂志, 2026, 48(6): 821-829. |
| [11] | 杜锡龙, 买吾拉江·依马木, 那颜, 帕孜力亚·牙生, 郭刚, 麦维兰江·阿不力米提, 张利萍, 郑彦玲. 复治肺结核治疗结局的最优预测模型构建[J]. 中国防痨杂志, 2026, 48(6): 830-839. |
| [12] | 刘麟, 殷小成, 张小佛, 梁麟龙, 杨炬. 1990—2023年全球0~14岁儿童结核病负担评估与2024—2050年趋势预测[J]. 中国防痨杂志, 2026, 48(6): 840-848. |
| [13] | 黄爱春, 兰艳群, 许超艳, 张洁, 李维文, 朱庆东, 谢周华. 结核病与艾滋病共病患者中影响γ-干扰素释放试验检测结果的相关因素分析[J]. 中国防痨杂志, 2026, 48(6): 849-855. |
| [14] | 蒋学峰, 周临军, 孙焱, 蒋明霞, 马玲, 梅蠡, 刘东鑫. 中国西北五省结核分枝杆菌耐药基因突变特征分析[J]. 中国防痨杂志, 2026, 48(6): 856-864. |
| [15] | 袁绍莹, 崔中锋, 杜江, 曹雪芳, 冯博轩, 何翼君, 李子涵, 赵雅琪, 于怡麟, 高磊, 辛赫男, 李洪智. QuantiFERON-TB Gold Plus检测在活动性肺结核诊断及治疗反应监测中的应用价值[J]. 中国防痨杂志, 2026, 48(6): 865-873. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||
京公网安备11010202007215号
ip访问总数: ip当日访问总数: 当前在线人数:
本作品遵循Creative Commons Attribution 3.0 License授权许可